Phospholipid metabolites in recurrent glioblastoma: in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy.

<h4>Purpose</h4>Metabolic changes upon antiangiogenic therapy of recurrent glioblastomas (rGBMs) may provide new biomarkers for treatment efficacy. Since in vitro models showed that phospholipid membrane metabolism provides specific information on tumor growth we employed in-vivo MR-spec...

Full description

Saved in:
Bibliographic Details
Main Authors: Elke Hattingen, Oliver Bähr, Johannes Rieger, Stella Blasel, Joachim Steinbach, Ulrich Pilatus
Format: article
Language:EN
Published: Public Library of Science (PLoS) 2013
Subjects:
R
Q
Online Access:https://doaj.org/article/7600f252df9b49f49e3e4c0871c525d7
Tags: Add Tag
No Tags, Be the first to tag this record!